Anita Gustavsson

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi request reprint No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer
    A Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Int J Radiat Oncol Biol Phys 43:745-54. 1999
  2. ncbi request reprint A systematic overview of radiation therapy effects in Hodgkin's lymphoma
    Anita Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Acta Oncol 42:589-604. 2003
  3. ncbi request reprint A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma
    Anita Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Acta Oncol 42:605-19. 2003
  4. ncbi request reprint Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
    Ingrid Glimelius
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University Hospital, Uppsala, Sweden
    Eur J Haematol 71:327-33. 2003
  5. ncbi request reprint Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy
    Gunilla Enblad
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Sweden
    Acta Oncol 41:659-67. 2002
  6. ncbi request reprint Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme
    Daniel Molin
    Department of Oncology, Radiology, and Clinical Immunology, University Hospital, Uppsala, Sweden
    Eur J Haematol 70:172-80. 2003
  7. ncbi request reprint FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre
    Maria Bjurberg
    Department of Oncology, Lund University Hospital, Lund, Sweden
    Acta Oncol 45:743-9. 2006
  8. ncbi request reprint Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients
    Mona Ridderheim
    Department of Oncology, University Hospital, 221 85 Lund, Sweden
    Support Care Cancer 11:371-7. 2003
  9. ncbi request reprint A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
    Rose Marie Amini
    Department of Oncology and Regional Oncological Centre, University Hospital of Uppsala, Sweden
    Eur J Haematol 68:225-32. 2002

Detail Information

Publications9

  1. ncbi request reprint No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer
    A Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Int J Radiat Oncol Biol Phys 43:745-54. 1999
    ..To assess cardiac mortality, coronary artery disease, myocardial dysfunction, and valvular heart disease in women younger than 65 years of age, at least 10 years after adjuvant radiotherapy following mastectomy in early breast cancer...
  2. ncbi request reprint A systematic overview of radiation therapy effects in Hodgkin's lymphoma
    Anita Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Acta Oncol 42:589-604. 2003
    ..Radiotherapy as salvage treatment might be an alternative in late limited nodal recurrence after initial chemotherapy. However, the body of knowledge is small. The role of radiotherapy in the treatment of HL is decreasing...
  3. ncbi request reprint A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma
    Anita Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Acta Oncol 42:605-19. 2003
    ..One randomized clinical trial is published, showing superior therapy results with radiolabelled antibody compared with the corresponding unlabelled antibody...
  4. ncbi request reprint Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
    Ingrid Glimelius
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University Hospital, Uppsala, Sweden
    Eur J Haematol 71:327-33. 2003
    ..In conclusion, we suggest that bulky disease should be taken into account when treating patients with stage IIB HL...
  5. ncbi request reprint Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy
    Gunilla Enblad
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Sweden
    Acta Oncol 41:659-67. 2002
    ..Thus efforts to improve the chemotherapy regimen with individualized dosing did not change the outcome. Many patients experienced myelosuppression and opportunistic infections that may have contributed to the poor treatment results...
  6. ncbi request reprint Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme
    Daniel Molin
    Department of Oncology, Radiology, and Clinical Immunology, University Hospital, Uppsala, Sweden
    Eur J Haematol 70:172-80. 2003
    ..These results favour the trend to treat early and intermediate stages with a short course of chemotherapy followed by limited RT...
  7. ncbi request reprint FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre
    Maria Bjurberg
    Department of Oncology, Lund University Hospital, Lund, Sweden
    Acta Oncol 45:743-9. 2006
    ..The high positive predictive value of FDG-PET in the residual group and the high negative predictive value in the relapse group strongly indicate that FDG-PET has an important role to play in the management of HL...
  8. ncbi request reprint Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients
    Mona Ridderheim
    Department of Oncology, University Hospital, 221 85 Lund, Sweden
    Support Care Cancer 11:371-7. 2003
    ..The aim of this study was to examine the efficacy and safety of a new digitized, controlled, scalp-cooling system to prevent chemotherapy-induced alopecia...
  9. ncbi request reprint A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
    Rose Marie Amini
    Department of Oncology and Regional Oncological Centre, University Hospital of Uppsala, Sweden
    Eur J Haematol 68:225-32. 2002
    ..Our aims were to evaluate the response to salvage treatment in relation to initial treatment and to evaluate prognostic factors at the time of relapse in an unselected population of relapsing patients with Hodgkin's lymphoma (HL)...